1.A Case of (21q 21q) Translocation Down Syndrome Inherited from a t(21q 21q) Balanced Carrier Mother.
Byeong Gie YEO ; Chong Woo BAE ; Yong Mook CHOI ; Chang Il AHN ; Bo Hoon OH
Journal of the Korean Pediatric Society 1990;33(7):1004-1008
No abstract available.
Down Syndrome*
;
Humans
;
Mothers*
2.Usefulness and Comparison of 201Tl - chloride, 99mTc - MIBI, 99mTc(V) - DMSA Single Photon Emission Computed Tomography in Distinguishing Lung Cancer from Benign Lesion.
Chang Ho KIM ; Sang Cheol CHAE ; Jae Yong PARK ; Tae Hoon JUNG ; Byeong Cheol AHN ; Jae Tae LEE
Tuberculosis and Respiratory Diseases 1996;43(5):720-727
Objectives : 201Tl - chloride, 99mTc - MIBI, 99mTc(V) - DMSA SPECT has been used in distinguishing lung cancer from benign lesion. To compare the diagnostic efficacy of SPECT with these tumor - seeking agents, we performed three consecutive SPECT using 201Tl, 99mTc - MIBI, 99mTc(V) - DMSA in same subjects with a solitary pulmonary lesion. Methods : SPECT was carried out at 10min and 3hr for 201Tl after injection of 2 mCi, and 2hr for 99mTc - MIBI and 99mTc(V) - DMSA after injection of 20mCi, respectively, in 37 patients with a solitary pulmonary lesion(27 lung cancer and 10 benign diseases). In patients showing visual uptake on lesion site, we obtained the lesion - to - bakground(target lesion/contralateral normal lung) uptake ratio from transverse slice for each radionuclide and also calculated the retention index for 201Tl. Results : The diagnostic sensitivity of 201Tl, 99mTc - MIBI and 99mTc(V) - DMSA SPECT to lung cancer was 100%, 96% and 73%, and the specificity was 40%, 70% and 70%, respectively. The low specificities for these agents were mainly due to high positive uptake in patients with active pulmonary tuberculosis. There were no significant differences in uptake ratios and retention index between malignant and benign lesions, and among the histologic types of lung cancer Conclusion : 201Tl and 99mTc - MIBI showed higher sensitivity than 99mTc(V) - DMSA for detecting lung cancer, but was of limited usefulness in distinguishing lung cancer from benign lesion due to low specificity, especially in area with a high prevalence of active pulmonary tuberculosis.
Humans
;
Lung Neoplasms*
;
Lung*
;
Prevalence
;
Sensitivity and Specificity
;
Succimer*
;
Tomography, Emission-Computed, Single-Photon*
;
Tuberculosis, Pulmonary
3.Usefulness and Comparison of 201Tl - chloride, 99mTc - MIBI, 99mTc(V) - DMSA Single Photon Emission Computed Tomography in Distinguishing Lung Cancer from Benign Lesion.
Chang Ho KIM ; Sang Cheol CHAE ; Jae Yong PARK ; Tae Hoon JUNG ; Byeong Cheol AHN ; Jae Tae LEE
Tuberculosis and Respiratory Diseases 1996;43(5):720-727
Objectives : 201Tl - chloride, 99mTc - MIBI, 99mTc(V) - DMSA SPECT has been used in distinguishing lung cancer from benign lesion. To compare the diagnostic efficacy of SPECT with these tumor - seeking agents, we performed three consecutive SPECT using 201Tl, 99mTc - MIBI, 99mTc(V) - DMSA in same subjects with a solitary pulmonary lesion. Methods : SPECT was carried out at 10min and 3hr for 201Tl after injection of 2 mCi, and 2hr for 99mTc - MIBI and 99mTc(V) - DMSA after injection of 20mCi, respectively, in 37 patients with a solitary pulmonary lesion(27 lung cancer and 10 benign diseases). In patients showing visual uptake on lesion site, we obtained the lesion - to - bakground(target lesion/contralateral normal lung) uptake ratio from transverse slice for each radionuclide and also calculated the retention index for 201Tl. Results : The diagnostic sensitivity of 201Tl, 99mTc - MIBI and 99mTc(V) - DMSA SPECT to lung cancer was 100%, 96% and 73%, and the specificity was 40%, 70% and 70%, respectively. The low specificities for these agents were mainly due to high positive uptake in patients with active pulmonary tuberculosis. There were no significant differences in uptake ratios and retention index between malignant and benign lesions, and among the histologic types of lung cancer Conclusion : 201Tl and 99mTc - MIBI showed higher sensitivity than 99mTc(V) - DMSA for detecting lung cancer, but was of limited usefulness in distinguishing lung cancer from benign lesion due to low specificity, especially in area with a high prevalence of active pulmonary tuberculosis.
Humans
;
Lung Neoplasms*
;
Lung*
;
Prevalence
;
Sensitivity and Specificity
;
Succimer*
;
Tomography, Emission-Computed, Single-Photon*
;
Tuberculosis, Pulmonary
4.Hormonal Treatment of Intestinal Cavernous Hemangioma Report of 2 cases.
Byeong Yul AHN ; Dong Hee LEE ; Hee Cheol KIM ; Gyeong Hoon KANG ; Jin Cheon KIM
Journal of the Korean Society of Coloproctology 2000;16(1):34-36
Cavernous hemangioma in the gastrointestinal tract is a rare benign vascular lesion, which can produce massive or persistent blood loss. Herein, we present two cases of gastrointestinal hemangiomas that could not be resected completely and were treated with estrogen because of multiple involvement of the gastrointestinal tract and viscera, including the anal canal. A 49-year-old male presented with unknown chronic melena and anemia. Preoperative work-up could not reveal the definite cause of bleeding. During exploration, hemangioma scattered in whole small bowel was identified and feeding vessel ligation was performed. Postoperative recurrent bleedings were controlled by additional estrogen therapy. A 25-year-old young woman had suffered from painless anal bleeding with subsequent anemia since her youth. She had diffuse carvernous hemangioma in the large intestine involving the anal canal and uterus. Total proctocolectomy and ileal-pouch anal anastomosis was performed, however the uterine hemangioma was left intact because the patient wanted to be pregnant. She was also treated with estrogen, postoperatively. It is suggested that estrogen may be a good alternative treatment modality for gastrointestinal hemangioma that can not be removed completely.
Adolescent
;
Adult
;
Anal Canal
;
Anemia
;
Estrogens
;
Female
;
Gastrointestinal Tract
;
Hemangioma
;
Hemangioma, Cavernous*
;
Hemorrhage
;
Humans
;
Intestine, Large
;
Ligation
;
Male
;
Melena
;
Middle Aged
;
Uterus
;
Viscera
5.Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors.
Ji hoon JUNG ; Byeong Cheol AHN
Brain Tumor Research and Treatment 2018;6(2):47-53
Brain tumors represent a diverse spectrum of histology, biology, prognosis, and treatment options. Although MRI remains the gold standard for morphological tumor characterization, positron emission tomography (PET) can play a critical role in evaluating disease status. This article focuses on the use of PET with radiolabeled glucose and amino acid analogs to aid in the diagnosis of tumors and differentiate between recurrent tumors and radiation necrosis. The most widely used tracer is ¹⁸F-fluorodeoxyglucose (FDG). Although the intensity of FDG uptake is clearly associated with tumor grade, the exact role of FDG PET imaging remains debatable. Additionally, high uptake of FDG in normal grey matter limits its use in some low-grade tumors that may not be visualized. Because of their potential to overcome the limitation of FDG PET of brain tumors, 11C-methionine and ¹⁸F-3,4-dihydroxyphenylalanine (FDOPA) have been proposed. Low accumulation of amino acid tracers in normal brains allows the detection of low-grade gliomas and facilitates more precise tumor delineation. These amino acid tracers have higher sensitivity and specificity for detecting brain tumors and differentiating recurrent tumors from post-therapeutic changes. FDG and amino acid tracers may be complementary, and both may be required for assessment of an individual patient. Additional tracers for brain tumor imaging are currently under development. Combinations of different tracers might provide more in-depth information about tumor characteristics, and current limitations may thus be overcome in the near future. PET with various tracers including FDG, ¹¹C-methionine, and FDOPA has improved the management of patients with brain tumors. To evaluate the exact value of PET, however, additional prospective large sample studies are needed.
Biology
;
Brain Neoplasms*
;
Brain*
;
Diagnosis
;
Electrons*
;
Glioma
;
Glucose
;
Gray Matter
;
Humans
;
Magnetic Resonance Imaging
;
Necrosis
;
Positron-Emission Tomography*
;
Prognosis
;
Prospective Studies
;
Radiopharmaceuticals*
;
Sensitivity and Specificity
6.Gas Forming Bacterial Infection after Total Knee Arthroplasty.
Je Gyun CHON ; Byeong Seop PARK ; Chi Hoon AHN ; Jong Won KANG
The Journal of the Korean Orthopaedic Association 2017;52(2):199-203
Postoperative gas-forming bacterial infection is very rare. However, it can be a life threatening problem if not properly addressed. Authors treated a patient who was infected with gas forming Escherichia coli after both knee arthroplasty with incision and drainage, as well as arthroscopic synovectomy and antibiotics. Herein, we report a case of postoperative gas-forming bacterial infection with literature review.
Anti-Bacterial Agents
;
Arthroplasty, Replacement, Knee*
;
Bacterial Infections*
;
Drainage
;
Escherichia coli
;
Humans
7.A case of respiratory bronchiolitis-associated interstitial lung disease.
Byeong Hoon AHN ; Hyung Suk PARK ; Jung Ho DO ; Gee Young SUH ; Man Pyo CHUNG ; Chong H RHEE ; Kwan Min KIM ; Kyung Soo LEE ; Jung ho HAN
Tuberculosis and Respiratory Diseases 1999;46(1):103-109
Respiratory bronchiolitis-associated interstitial lung disease has been described among current or former smokers and has features consistent with interstitial lung disease. Symptoms include cough, dyspnea on exertion. Lung pathology is characterized by the accumulation of pigmented macrophages within respiratory bronchioles and adjacent air spaces associated with mild thickening of the peribronchiolar interstitium. It must be separated from the other interstitial lung disease because of marked differences in treatment and prognosis. Recently we experienced a case of respiratory bronchiolitis -associated interstitial lung disease in a 48-year-old man. As far as we know, this is the first case in Korea.
Bronchioles
;
Bronchiolitis
;
Cough
;
Dyspnea
;
Humans
;
Korea
;
Lung
;
Lung Diseases, Interstitial*
;
Macrophages
;
Middle Aged
;
Pathology
;
Prognosis
;
Smoking
8.Early Diagnosis and Improved Survival with Screening for Hepatocellular Carcinoma.
Chung Mee YOUK ; Moon Seok CHOI ; Seung Woon PAIK ; Byeong Hoon AHN ; Joon Hyeok LEE ; Kwang Cheol KOH ; Byung Chul YOO ; Jong Chul RHEE
The Korean Journal of Hepatology 2003;9(2):116-123
BACKGROUND/AIMS: Screening for hepatocellular carcinoma (HCC) is a common practice in the endemic countries but its exact role has not been fully investigated. The purpose of this study was to determine whether screening can achieve early diagnosis and survival benefits. METHODS: All HCC patients diagnosed at our hospital (September 1994~April 2000) were enrolled; They were divided into two groups; a surveilled group screened with alpha-fetoprotein (AFP) and ultrasound (US) for longer than 6 months before diagnosis and a non-surveilled group. We compared the tumor size, portal vein thrombosis, and stage at initial diagnosis and survival rate between the two groups. RESULTS: A total of 247 patients were enrolled. 64 were in the surveilled group and 183 were in the non-surveilled group. The tumor size at initial diagnosis in the surveilled group was smaller than in the non-surveilled group (2.6+/-2.0 cm vs. 5.7+/-4.1 cm, p<0.05). The percentages of patients with stage I, II, III, and IV were 42.2%, 20.3%, 14.1%, 23.4% in the surveilled group and 8.7%, 19.7%, 36.6%, 35.0% in the non-surveilled group. A significantly higher proportion in the surveilled group had earlier stage compared with the non-surveilled group (p<0.05). Portal vein thrombosis in the surveilled group was noticed as significantly less than in the non-surveilled group (9.4% vs. 26.8%, p<0.05). Among Child-Pugh A patients, the cumulative survival rate in the surveilled group was significantly higher than in the non-surveilled group (1 year; 91.4% vs. 70.7%, 2 year; 71.5% vs. 59.9%, p<0.05). CONCLUSIONS: Screening with AFP and US is a useful tool for early diagnosis of HCC, especially with improved survival in Child-Pugh A patients.
Adult
;
Aged
;
Carcinoma, Hepatocellular/*diagnosis/mortality/therapy
;
Female
;
Humans
;
Liver Neoplasms/*diagnosis/mortality/therapy
;
Male
;
Middle Aged
;
Survival Rate
;
alpha-Fetoproteins/analysis
9.Correction of Severely Asymmetric Calf using Latissimus Dorsi Musculocutaneous Free Flap and Customized Silicone Implant.
Min Su JUNG ; Hii Sun JEONG ; Byeong Ho LEE ; Joo Hyun KIM ; Seong Hoon PARK ; Duk Kyun AHN ; In Suck SUH
Archives of Aesthetic Plastic Surgery 2014;20(2):124-127
Calves can be easily seen in daily life and are an important part of the body contour. Asymmetric calves can develop from unbalanced distribution and deposition of fat and muscles between the legs. Calf asymmetry may be due to congenital factors, disease (e.g., poliomyelitis, cerebral palsy, or infection), spinal cord injury, or the effects of surgical treatment and may have severe adverse psychological and social implications. Generally, an asymmetric calf is diagnosed when the difference of the longest circumference between both calves is more than 2 cm. Several surgical methods have been introduced for the correction of an asymmetric calf. Implant insertion or fat injection is used to augment a hypotrophic calf. Selective neurectomy, liposuction, muscle resection, radiofrequency, and botulinum toxin injection are used to treat a hypertrophic calf. With the development of microsurgery, the authors planned to use a latissimus dorsi musculocutaneous free flap (LDMC free flap) with silicone implant to add calf volume to obtain natural calf contour. The authors present the first successful case of correction of a severely asymmetric calf using an LDMC free flap and customized silicone implant.
Botulinum Toxins
;
Cerebral Palsy
;
Free Tissue Flaps*
;
Leg
;
Lipectomy
;
Lower Extremity
;
Microsurgery
;
Muscles
;
Poliomyelitis
;
Silicones*
;
Spinal Cord Injuries
;
Superficial Back Muscles*
10.Treatment of Botulinum Toxin Type A in Parotid Fistula after Face Lifting.
Min Su JUNG ; Byeong Ho LEE ; Joo Hyun KIM ; Seong Hoon PARK ; Duk Kyun AHN ; Hii Sun JEONG ; In Suck SUH
Archives of Aesthetic Plastic Surgery 2014;20(2):120-123
Botulinum toxin type A has an inhibitory action not only on neuromuscular junctions, but also postganglionic sympathetic and cholinergic autonomic parasympathetic acetylcholine release at the secretary end of the salivary gland. Use of botulinum toxin to treat sialorrhea was first reported in 1997 by Bushara. Parotid duct or gland injuries with parotid fistula are uncommon but troublesome complications of surgical trauma. Here, we report two patients with constant leakage of serous fluid and a swelling cheek after facelift surgery. Each patient underwent an amylase test, starch iodine test, and sialography. After diagnosis of parotid fistula, a total of 50 units botulinum toxin was injected into the parotid gland. Facial bandage, scopolamine, and minimizing temporomandibular joint motion were instructed. Leakage volume decreased gradually, and symptoms subsided within 2 weeks. Neither functional problems nor complications occurred. In conclusion, a parotid fistula after facial surgery can be treated effectively with botulinum toxin; this treatment option should be considered before proceeding with invasive surgical treatment.
Acetylcholine
;
Amylases
;
Bandages
;
Botulinum Toxins
;
Botulinum Toxins, Type A*
;
Cheek
;
Diagnosis
;
Fistula*
;
Humans
;
Iodine
;
Neuromuscular Junction
;
Parotid Gland
;
Rhytidoplasty*
;
Salivary Glands
;
Scopolamine Hydrobromide
;
Sialography
;
Sialorrhea
;
Starch
;
Temporomandibular Joint